HOOK
HOOKIPA PHARMA INC.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies 2× in & out | Q4 2024 | Q4 2025 | → $0.87 | -74% |
| Citadel Advisors | Q4 2024 | Q3 2025 | → $0.83 | -74% |
| Millennium Management 2× in & out | Q1 2025 | Q2 2025 | → $1.45 | -23% |
| Two Sigma Investments | Q3 2024 | Q4 2024 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at HOOKIPA Pharma Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Oct 9, 2025 — the most recent Form 4 on file — not from today.
- Form 40001876563-25-000004Oct 9, 2025
- Form 40001415889-25-020200Jul 23, 2025
- Form 40001415889-25-020198Jul 23, 2025
- Form 40001415889-24-020043Jul 24, 2024
- Form 40001415889-24-020042Jul 24, 2024
- Form 40001415889-24-020041Jul 24, 2024
- Form 40001415889-24-017391Jun 18, 2024
- Form 40001415889-24-017393Jun 18, 2024
- Form 40001415889-24-017390Jun 18, 2024
- Form 40001415889-24-017387Jun 18, 2024
- Form 40001415889-24-017388Jun 18, 2024
- Form 40001415889-24-017386Jun 18, 2024
- Form 40001415889-24-010961Apr 17, 2024
- Form 40001415889-24-010960Apr 17, 2024
- Form 40001415889-24-010963Apr 17, 2024
Fundamentals
XBRL · HOOKIPA PHARMA INC.Annual figures sourced directly from HOOKIPA PHARMA INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for HOOKIPA Pharma Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KJul 29, 2025
- 8-KFORM 8-KJul 18, 2025
- 8-KFORM 8-KMay 22, 2025
- 10-QQuarterly reportMay 15, 2025
- 10-K/AFORM 10-K/AApr 30, 2025
- 10-KAnnual reportFeb 28, 2025
- 8-KFORM 8-KFeb 20, 2025
- 8-KFORM 8-KJan 29, 2025
- 8-KFORM 8-KJan 10, 2025
- 8-KFORM 8-KJan 7, 2025
- 8-KFORM 8-KJan 2, 2025
- 8-KFORM 8-KNov 20, 2024
- SC 13G/A5%+ ownership (amended)Nov 14, 2024
- 10-QQuarterly reportNov 14, 2024
- 8-KMaterial eventNov 14, 2024
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q1 2025 | Q2 2025 | $1.89 | $1.45 | -23% |
| Citadel Advisors | Q4 2024 | Q3 2025 | $3.14 | $0.83 | -74% |
| Renaissance Technologies | Q4 2024 | Q4 2025 | $3.42 | $0.87 | -74% |
| Two Sigma Investments | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Millennium Management | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Renaissance Technologies | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.